Sinopsis
Interviews with the top thought leaders in medicine exploring the clinical and professional issues that are foremost in the minds of the medical community. Join us at the Clinician's Roundtable for discussions on a vast range of topics that every medical professional should know about.
Episodios
-
Treating Children with ADHD and Anxiety Disorders
24/09/2008Host: Leslie P. Lundt, MD Guest: Katharina Manassis, MD Children with the common presentation of both anxiety disorders and ADHD require a four-pronged treatment approach. What are the mainstays of treatment? Host Dr. Leslie Lundt welcomes Dr. Katharina Manassis, associate professor in the department of psychiatry at the University of Toronto, to discuss how to treat children with both ADHD and anxiety.
-
Debulking Surgery and HIPC to Treat Ovarian Cancer
24/09/2008Host: Leslie P. Lundt, MD Guest: Robert E. Bristow, MD According to the American Cancer Society, over 21,000 new cases of ovarian cancer are diagnosed each year with 15,000 more women dying annually. What are the recent developments in research to improve these odds? Dr. Robert Bristow, the director of the Kelly Gynecologic Oncology Service and the Johns Hopkins Ovarian Cancer Center of Excellence, joins host Dr. Leslie Lundt to discuss the value of debulking surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer.
-
Sudden Cardiac Death Prevention: ICD Indications
23/09/2008Host: Matthew J. Sorrentino, MD, FACC, FASH Guest: Jeanne Poole, MD Patients with advanced heart failure are at increased risk for sudden cardiac arrest, but many of them are not receiving ICD therapy. Dr. Jeanne Poole, professor of medicine and cardiology at the University of Washington, Seattle, will review with host Dr. Matthew Sorrentino the indications for ICD therapy in patients with congestive heart failure.
-
Prognostic Importance of Defibrillator Shock
23/09/2008Host: Matthew J. Sorrentino, MD, FACC, FASH Guest: Jeanne Poole, MD Recent studies show that patients who receive an ICD shock, either appropriately or inappropriately, have a higher risk of death. Dr. Jeanne Poole, professor of Medicine and Cardiology at the University of Washington, Seattle shares with host, Dr. Matthew Sorrentino the prognostic importance of defibrillator shocks in patients with congestive heart failure.
-
A New Outreach Program to Find College Students at Risk for Suicide
22/09/2008Host: Cathleen Margolin, PhD Guest: Steven Garlow, MD, PhD Host Dr. Cathleen Margolin interviews Dr. Steven Garlow of Emory University School of Medicine about his recently published article in the Journal of American College Health. Dr. Garlow and colleagues studied an interactive web-based method of outreach to college students at risk for suicide.
-
Special Populations At Risk for Suicide: Young Adults and Physicians
22/09/2008Host: Cathleen Margolin, PhD Guest: Steven Garlow, MD, PhD Dr. Steven Garlow of the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine joins host, Dr. Cathleen Margolin, to talk about the challenges of finding young adults who are at risk for suicide. He also discusses the elevated risk of suicide among physicians.
-
Assessing Suicide Risk in Young Adults
22/09/2008Host: Cathleen Margolin, PhD Guest: Steven Garlow, MD, PhD What are the key warning signs of a potential suicide in young adults? How can we, as clinicians, act to prevent these devastating tragedies from occurring? Dr. Steven Garlow, assistant professor of psychiatry at Emory University School of Medicine, discusses suicide prevention for the post-high school population with host Dr. Cathleen Margolin.
-
Employment Agreements for Physician Assistants
22/09/2008Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA Guest: Michele Roth-Kauffman, JD, PA-C Michele Roth-Kauffman, a physician assistant and attorney, discusses the differences between employing a physician assistant with and without written contract. In addition, Ms. Roth-Kauffman identifies the key terms of a written employment agreement, such as salary, employment term, liability insurance and scope of practice. Ms. Roth-Kauffman highlights those terms of employment which should be clearly specified if the employer choses to employ the physician assistant under an agreement.
-
Malpractice Insurance Options for Your Physician Assistant
22/09/2008Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA Guest: Michele Roth-Kauffman, JD, PA-C Host Lisa D'Andrea welcomes guest Michele Roth-Kauffman, a physician assistant and an attorney. Ms. Roth-Kauffman discusses the various options available to practice owners for providing malpractice coverage to physician assistants working in the practice. Ms. Roth-Kauffman also advises practice owners and physician assistants about the type and scope of coverage required for physician assistants working part-time or for two independent medical practices.
-
Malpractice Coverage for Physician Assistants
22/09/2008Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA Guest: Michele Roth-Kauffman, JD, PA-C Host Lisa D'Andrea welcomes Michele Roth-Kauffman, chair of the physician assistant department at Gannon University in Erie, Pennsylvania, and an attorney, to discuss coverage options available to the physician assistants, the limitations of such coverage, and how the physician can enhance his/her own coverage to afford greater protection against malpractice claims. Ms. Roth-Kauffman also shares other steps you can take to reduce malpractice exposure.
-
Current Surgical and Non-Surgical Techniques in Articular Cartilage Repair
19/09/2008Host: Sherwin Ho, MD Guest: Riley J. Williams III, MD When articular cartilage is damaged orthopedic intervention is required. Dr. Riley Williams, associate professor of orthopedic surgery at Weill Medical College, director of the institute for cartilage repair at the Hospital for Special Surgery, and a leading expert on cartilage repair, joins host Dr. Sherwin Ho to talk about current surgical and non-surgical techniques for repairing tissue. Find out also what Dr. Williams is learning from clinical trials on an updated version of an ACI procedure.
-
Unscrambling the Egg Myth
19/09/2008Guest: Stephen Kritchevsky, PhD For much of the past 40 years, doctors have been telling patients vulnerable to heart disease to avoid eating eggs because of a mistaken belief that cholesterol-rich eggs increased one's risk of coronary heart disease. Guest Dr. Stephen B. Kritchevsky, director of the Claude D. Pepper Older Americans Independence Center supported by the National Institute on Aging, reviews the scientific research concerning cardiovascular disease and egg consumption with host Dr. Larry Kaskel.
-
Medical Depots for America's Truck Drivers
19/09/2008Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA Guest: John McElligott, MD,FACP, MPH Truck drivers live to an average age of 55, and thirty drivers are found dead each day in their trucks according to Dr. John McElligott, medical director of Professional Drivers Medical Depots. Dr. McElligott, explains to host Lisa D'Andrea how these statistics fueled his desire to provide convenient and affordable healthcare to the thousands of drivers in America. Dr. McElligott describe the model of the medical clinics, which are located at truck stops off major interstates highways. Dr. McElligott indicates that utilizing physician assistants to provide care makes the trucking clinics financially viable. Dr. McElligott also describes other services provided by the clinics such as taking care of a driver's truck, flexible appointments, and parking for these large vehicles, which are necessary in order to make 'healthcare' accessible for truck drivers.
-
Pharma and Biotech Industries Pursue Treatments for Cardiac Inflammation
17/09/2008Host: Bruce Japsen Guest: Lawrence Cohen, PhD A treatment for atherosclerosis and the chronic inflammation in arterial blood vessels could be entering critical clinical trial stages that may result in a novel new treatment. Dr. Lawrence Cohen, president and chief executive officer of VIA Pharmaceuticals lays out for host Chicago Tribune's Bruce Japsen the landscape of large pharmaceutical companies as well as smaller biotech companies that are making progress in bringing these treatments through the clinical trial process. They are closer than you might think.
-
Treatments for Cardiac Blood Vessel Inflammation In the Works
17/09/2008Host: Bruce Japsen Guest: Lawrence Cohen, PhD Why aren't there medications to treat atherosclerosis or, more specifically, the underlying chronic inflammation of the blood vessel walls associated with this condition? Dr. Lawrence Cohen, president and CEO of VIA Pharmaceuticals, tells the Chicago Tribune's Bruce Japsen about the coming medications in U.S.-approved clinical trials to treat this inflammatory process.
-
After More Than 150 Years, Recent Progress in Atherosclerosis Treatment
17/09/2008Host: Bruce Japsen Guest: Lawrence Cohen, PhD For more than 150 years, medical researchers have known that atherosclerosis had an inflammatory component. But Dr. Lawrence Cohen, president and CEO of VIA Pharmaceuticals tells host Bruce Japsen of the Chicago Tribune why there has not been anything done about it.
-
Neonatal Stroke: More Common Than We Know?
17/09/2008Host: Jennifer Shu, MD, FAAP Guest: E. Steve Roach, MD Stroke has been increasingly recognized among children in recent years. Stroke in neonates, in particular, occurs at a much higher rate than in older children. What are the leading risk factors for neonatal stroke? How does it present and how is it diagnosed? Host Dr. Jennifer Shu learns more about the evidence for managing stroke in newborns, as well as the likely short-term and long-term outcomes, from Dr. E. Steve Roach, professor of pediatrics and neurology at the Ohio State University College of Medicine, and chief of the division of child neurology at Nationwide Children's Hospital in Columbus, Ohio.
-
Advances in Viral Immunity Stemming from the 1918 Flu Pandemic
16/09/2008Host: Mark Nolan Hill, MD Guest: James Crowe, MD Preparing for the future by studying the past: With researchers now able to resurrect antibodies to the 1918 influenza pandemic from elderly survivors, how does the technology used to do this potentially lead us to antibodies for other viruses? Can we be sure this immunity is not generated by recent exposure to similar strains? Dr. James Crowe, Jr., professor of microbiology and immunology, and director of the Vanderbilt Program for Vaccine Sciences at Vanderbilt University School of Medicine, and one of the researchers leading this expansive project, explains how we are beginning to learn more about where viruses, including HIV, are most susceptible to being controlled and destroyed. Dr. Mark Nolan Hill hosts.
-
Antibodies Derived from the 1918 Flu Pandemic: Still Potent?
16/09/2008Host: Mark Nolan Hill, MD Guest: James Crowe, MD Ninety-plus years after the 1918 influenza pandemic, we are just beginning to understand the naturally occurring adaptive immunity of those who were in contact with this devastating virus. As researchers probe survivors of the flu pandemic, all of whom are approaching or have attained centenarian status, what are we learning about their long-lasting immunity to this virus? Can we explain why these people survived this expansive outbreak, just as relatives and friends around them perished? Dr. James Crowe, Jr., professor of microbiology and immunology, and director of the Vanderbilt Program for Vaccine Sciences at Vanderbilt University School of Medicine, and one of the researchers leading this expansive project, shares some of the tricks that his team has used to make these antibodies in this fascinating discussion with Dr. Mark Nolan Hill.
-
Resurrecting Antibodies from 1918 Flu Pandemic Survivors
16/09/2008Host: Mark Nolan Hill, MD Guest: James Crowe, MD First published in 2005, the story of how we've come to understand the complete sequence of the 1918 pandemic influenza virus begins years ago, in a remote Alaskan village, and continues today in research across the country. What are we learning about a virus that has taken many decades to comprehend? Dr. James Crowe, Jr., professor of microbiology and immunology, and director of the Vanderbilt Program for Vaccine Sciences at Vanderbilt University School of Medicine, and one of the researchers leading this expansive project, tells host Dr. Mark Nolan Hill that antibody recognition may actually bear a strong resemblance to cognitive memory. What does Dr. Crowe mean by this? Do we know how the immune system would respond if survivors were infected with this influenza virus?